NC BREATHE 2025: AstraZeneca Premier Sponsor

CleanAIRE NC Announces AstraZeneca as Premier Sponsor for 10th Annual NC BREATHE Conference

CleanAIRE NC is delighted to announce that AstraZeneca, a global biopharmaceutical company, has signed on as the Premier Sponsor for the 10th annual NC BREATHE Conference. This milestone conference, focusing on planetary and community health solutions for the future, is scheduled for October 8 – 9, 2025, at the Harris Conference Center in Charlotte, NC.

AstraZeneca’s commitment as Premier Sponsor underscores a shared dedication to improving public health and addressing the critical intersection of environmental and human well-being. Their support will be instrumental in expanding the reach and impact of NC BREATHE 2025, which will explore how we can strengthen community health and environmental resilience across North Carolina.

“AstraZeneca’s partnership plays a pivotal role in strengthening public-private healthcare collaboration and ensuring meaningful participation from community leaders, nonprofit organizations, students, and health professionals statewide,” said Jeffrey Robbins, Executive Director of CleanAIRE NC. “Their leadership in the biopharmaceutical sector and their commitment to health innovation align perfectly with our mission to create healthier communities.”

Strengthening Community Health Through Partnership

NC BREATHE 2025 will serve as a vital forum for community leaders, advocates, health professionals, policymakers, and students to collaborate on strategies for building healthier, more resilient communities through interdisciplinary collaboration and research-informed, community-centered approaches.

As the Premier Sponsor, AstraZeneca will receive significant opportunities to engage with and contribute to the conference’s agenda, including prominent speaking opportunities to share AstraZeneca’s current initiatives and latest research, and preferential placement for an exhibitor table in the conference’s networking event space.

The new partnership highlights the growing recognition that addressing complex health equity challenges requires cross-sector collaboration and shared leadership.

“AstraZeneca’s support—at a time when resilience is more essential than ever—is both timely and action-driven,” said Madison Fragnito, Development Director with CleanAIRE NC. “Through this collaboration, we remain committed to deep listening, showing up for communities, and driving real, lasting impact.”

Registration for NC BREATHE 2025 is now open. For more information about the conference, including the agenda, speakers, and registration details, please visit http://cleanairenc.org/nc-breathe-2025/.